CHEO
CHEO is seeking a full-time, permanent Clinical Scientist - Molecular to join the molecular laboratory of Newborn Screening Ontario. This hybrid role involves interpreting and reporting molecular diagnostic data, evaluating genetic variants, and overseeing assay development and validation. The position also includes participating in quality assurance, training, and contributing to a scholarly program within the lab.
Welcome to the new CHEO website, where you can access all our services in one user-friendly portal!
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CHEO.
25% below the average for this role
Clinical Scientist, Newborn Screening Ontario - Permanent Full-Time (1.0) / Chercheuse ou chercheur clinique en sciences, Dépistage neonatal Ontario - permanente à temps plein (1.0)
Children's Hospital of Eastern Ontario - Ottawa Children's Treatment Centre
Molecular Geneticist
Caris Life Sciences
Principal Clinical Molecular Geneticist
Abbott Laboratories
Sr Manager Molecular Analysis
Taconic Biosciences, Inc.
Specialty Technologist, Newborn Screening Ontario – Permanent Full Time (1.0) / Technologue spécialisé(e), Dépistage néonatal Ontario - poste permanent à temps plein (1,0)
Children's Hospital of Eastern Ontario - Ottawa Children's Treatment Centre
Molecular Geneticist
Caris Life Sciences